Journal
JOURNAL OF MAGNETIC RESONANCE IMAGING
Volume 33, Issue 3, Pages 647-654Publisher
WILEY
DOI: 10.1002/jmri.22480
Keywords
amide proton transfer; chemical exchange saturation transfer; prostate cancer; mobile protein level; molecular imaging
Funding
- AUA Foundation
- EUSA Pharma (USA), Inc
- Wright Center of Innovation in Biomedical Imaging
Ask authors/readers for more resources
Purpose: To evaluate the capability of amide proton transfer (AFT) MR imaging for detection of prostate cancer that typically shows a higher tumor cell proliferation rate and cellular density leading to an MRI-detectable overall elevated mobile protein level in higher grade tumors. Materials and Methods: Twelve patients with biopsy-proven prostate cancer were imaged on a 3 Testa MR imaging system before prostatectomy. APT-MR images were acquired by means of a single-slice single-shot turbo spin echo sequence with a saturation prepulse preparation using 33 different frequency offsets (-8 to 8 ppm, interval 0.5 ppm). For quantification we used the APT ratio (APTR) based on the asymmetry of the magnetization transfer ratio at 3.5 ppm in respect to the water signal. Tumor and peripheral zone benign regions of interest (ROIs) were delineated based on whole mount pathology slides after prostatectomy. Results: APTR in prostate cancer ROIs was 5.8% +/- 3.2%, significantly higher than that in the peripheral zone benign regions (0.3% +/- 3.2%, P = 0.002). Conclusion: APT-MR imaging is feasible in prostate cancer detection and has the potential to discriminate between cancer and noncancer tissues.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available